VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2026)

VitaNova Life Sciences' (VNOV) quarterly Share-based Compensation came in at $179400.0 in Q2 2026, up 35780.0% on a QoQ basis from $500.0 in Q1 2025.

VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2026) Analysis & Trends

VitaNova Life Sciences (VNOV) has 3 years of Share-based Compensation data on file, last reported at $179400.0 in Q2 2026.

Quarterly Share-based Compensation changed N/A year-over-year to $179400.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $179400.0 (up 8870.0% YoY) and the FY2026 annual result came in at $179400.0, up 8870.0% from the prior year.
Share-based Compensation improved to $179400.0 in Q2 2026, from $500.0 in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $179400.0 in Q2 2026 to a low of $500.0 in Q1 2025.
A 3-year average of $36480.0 and a median of $750.0 in 2024 frame the typical range for Share-based Compensation.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Mckesson	102.64 Bn	97.48 Bn	3.69 Bn	-
2	Cencora	61.42 Bn	58.60 Bn	3.61 Bn	17.60 Mn
3	Cardinal Health	54.18 Bn	49.32 Bn	2.56 Bn	58.00 Mn
4	Henry Schein	10.03 Bn	9.87 Bn	1.10 Bn	7.00 Mn
5	Akso Health	676.38 Mn	676.18 Mn	-	-
6	Edap Tms	155.55 Mn	134.01 Mn	7.34 Mn	855,000.00
7	Accendra Health	92.42 Mn	84.77 Mn	263.41 Mn	3.15 Mn
8	111	30.17 Mn	-28.59 Mn	18.18 Mn	-
9	Cosmos Health	13.08 Mn	10.63 Mn	1.51 Mn	558,858.00
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	179,400.00

Download Data